Parties d'ouvrages collectifs (2)
  1. 1. De Vriese, C., Perret, J., & Delporte, C. (2014). Current and future clinical applications of ghrelin. In Endocrine Diseases (pp. 65-102). IConcept Press Ltd.
  2. 2. De Vriese, C., Perret, J., & Delporte, C. (2009). Ghrelin: a peptide involved in the control of appetite. In Appetite and nutritional assessment (pp. 1-48). New York, USA: Ellsworth S.J. and Schuster R.C.(Nova Science Publishers Inc.).
    3.   Articles dans des revues avec comité de lecture (39)
  3. 1. Schils, A., Lechon, A.-S., Rondeaux, S., Souard, F., Van Laethem, J.-L., Pochet, S., Mathieu, V., & De Vriese, C. (2023). Cancer patients' behaviors and attitudes toward natural health products. BMC complementary medicine and therapies, 23(1), 442, 1-14. doi:10.1186/s12906-023-04278-0
  4. 2. Macé, F., De Vriese, C., Nelissen-Vrancken, M., Ruggli, M., Brülhart, M., & Peyron, C. (2023). General practitioners-community pharmacists pharmacotherapy discussion groups: Analysis of their implementation through a series of case studies. Exploratory research in clinical and social pharmacy, 12, 100331. doi:10.1016/j.rcsop.2023.100331
  5. 3. Biset, N., Lelubre, M., Pochet, S., & De Vriese, C. (2023). Asthma and COPD: Comparison with International Guidelines and Medication Adherence in Belgium. Pharmaceuticals, 16(7). doi:10.3390/ph16071030
  6. 4. Rondeaux, S., Braeckman, T., Beckwé, M., El Oueriaghli El Ghammaz, D., Devroey, D., & De Vriese, C. (2023). Design and Development of Tools for Risk Evaluation of Diabetes and Cardiovascular Disease in Community Pharmacy. International journal of environmental research and public Health, 20(4). doi:10.3390/ijerph20042819
  7. 5. Pochet, S., Lechon, A.-S., Lescrainier, C., De Vriese, C., Mathieu, V., Hamdani, J., & Souard, F. (2022). Herb-anticancer drug interactions in real life based on VigiBase, the WHO global database. Scientific reports, 12(1), 14178. doi:10.1038/s41598-022-17704-z
  8. 6. Rondeaux, S., Braeckman, T., Beckwé, M., Biset, N., Maesschalck, J., Duquet, N., De Wulf, I., Devroey, D., & De Vriese, C. (2022). Diabetes and Cardiovascular Diseases Risk Assessment in Community Pharmacies: An Implementation Study. International journal of environmental research and public Health, 19(14). doi:10.3390/ijerph19148699
  9. 7. Biset, N., Kestens, W., Detemmerman, D., Lona, M., Karakaya, G., Ceuppens, A., Pochet, S., & De Vriese, C. (2022). Analysis of the Consumption of Drugs Prescribed for the Treatment of Asthma in Belgian Children. International Journal of Environmental Research and Public Health, 19(1), 548. doi:10.3390/ijerph19010548
  10. 8. Koubaity, M., Lechon, A.-S., Amighi, K., Van Nuffelen, M., Moreau, M., Meert, A.-P., & De Vriese, C. (2021). Drug-related problems and risk factors related to unplanned hospital readmission among cancer patients in Belgium. Supportive care in cancer. doi:10.1007/s00520-020-05916-w
  11. 9. Wuyts, J., Maesschalck, J., De Wulf, I., Lelubre, M., Foubert, K., De Vriese, C., Boussery, K., Goderis, G., De Lepeleire, J., & Foulon, V. (2020). Studying the impact of a medication use evaluation by the community pharmacist (Simenon): Drug-related problems and associated variables. Research in social & administrative pharmacy : RSAP, 16(8), 1100-1110. doi:10.1016/j.sapharm.2019.11.008
  12. 10. Foubert, K., Mehuys, E., Maesschalck, J., De Wulf, I., Wuyts, J., Foulon, V., Lelubre, M., De Vriese, C., Somers, A., Petrovic, M., & Boussery, K. (2019). Pharmacist-led medication review in community-dwelling older patients using the GheOP3 S-tool: General practitioners' acceptance and implementation of pharmacists' recommendations. Journal of evaluation in clinical practice, 26, 962-972. doi:10.1111/jep.13241
    13. << Précédent 1 2 3 4 5 6 7 8 9 Suivant >>